SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Carcinogenesis

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/carcin/bgt098PMID 23514751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment

  2012cited by this paper
• Modulation of glutamine metabolism by the PI(3)K–PKB–FOXO network regulates autophagy

  2012cited by this paper
• ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance

  2011cited by this paper
• Cellular and molecular effects of sirtuins in health and disease.

  2011cited by this paper
• Chromatin regulation and genome maintenance by mammalian SIRT6.

  2011cited by this paper
• Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer.

  2011cited by this paper
• Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer

  2011cited by this paper
• SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells

  2011cited by this paper
• SIRT6 Promotes DNA Repair Under Stress by Activating PARP1

  2011influential reference
• Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.

  2011cited by this paper
• Human SIRT6 Promotes DNA End Resection Through CtIP Deacetylation

  2010cited by this paper
• Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity

  2010cited by this paper
• Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer

  2010cited by this paper
• The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability

  2009cited by this paper
• Treatment options for breast cancer resistant to anthracycline and taxane.

  2009cited by this paper
• SIRT6 stabilizes DNA-dependent Protein Kinase at chromatin for DNA double-strand break repair

  2009influential reference
• Studying the subcellular localization and DNA-binding activity of FoxO transcription factors, downstream effectors of PI3K/Akt.

  2009cited by this paper
• SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin

  2008cited by this paper
• Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.

  2008cited by this paper
• A Phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.

  2008cited by this paper
• Cellular mechanisms of resistance to anthracyclines and taxanes in cancer: intrinsic and acquired.

  2008cited by this paper
• A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells.

  2008cited by this paper
• SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation.

  2007cited by this paper
• Strong expression of a longevity-related protein, SIRT1, in Bowen’s disease

  2007cited by this paper
• Targeting the microtubules in breast cancer beyond taxanes: the epothilones.

  2007cited by this paper
• Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2

  2006cited by this paper
• Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.

  2006influential reference
• DNA damage evaluated by gammaH2AX foci formation by a selective group of chemical/physical stressors.

  2006cited by this paper
• Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.

  2006cited by this paper
• Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins.

  2005cited by this paper
• Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.

  2005influential reference
• Mouse Sir2 Homolog SIRT6 Is a Nuclear ADP-ribosyltransferase*

  2005cited by this paper
• Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.

  2005cited by this paper
• Molecular mechanisms of drug resistance

  2005cited by this paper
• Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors

  2005cited by this paper
• The Role of Taxanes in the Adjuvant Treatment of Early Stage Breast Cancer

  2004cited by this paper
• Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase

  2004cited by this paper
• FoxO3a Transcriptional Regulation of Bim Controls Apoptosis in Paclitaxel-treated Breast Cancer Cell Lines*

  2003cited by this paper
• The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide–dependent deacetylase

  2002cited by this paper
• DNA and its associated processes as targets for cancer therapy

  2002cited by this paper
• ATP-bound Topoisomerase II as a Target for Antitumor Drugs*

  2001cited by this paper
• Mitochondria as subcellular targets for clinically useful anthracyclines.

  2001cited by this paper
• Paclitaxel‐induced cell death

  2000cited by this paper
• A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.

  2000cited by this paper
• A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.

  1999cited by this paper
• Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death.

  1996cited by this paper
• Reactive oxygen species and programmed cell death.

  1996cited by this paper
• A simple technique for quantitation of low levels of DNA damage in individual cells.

  1988cited by this paper
• Taxol: an antimitotic agent with a new mechanism of action.

  1984cited by this paper

• Lead Optimization: Synthesis and Biological Evaluation of Griseofulvin Derivatives as Novel SIRT6 Activators

  2026cites this paper
• SIRT6: From molecular functions to a potential therapeutic target in human disease

  2026cites this paper
• miR‐338‐3p Targets SIRT6 to Inhibit Liver Cancer Malignancy and Paclitaxel Resistance

  2025cites this paper
• Design and synthesis of guanidino derivatives of benzoate esters as SIRT6 inhibitors.

  2025cites this paper
• Pharmacological activation of SIRT6 suppresses progression of head and neck and esophageal squamous cell carcinoma by modulation of cellular metabolism and protein translation

  2025cites this paper
• Nanoparticle-based approaches for doxorubicin delivery in hepatocellular carcinoma: Current strategies and emerging innovations.

  2025cites this paper
• Cyperotundone promotes chemosensitivity of breast cancer via SRSF1

  2025cites this paper
• The Chemopreventive Effect of Ginsenoside Compound K Is Regulated by PARP-1 Hyperactivation, Which Is Promoted by p62-Dependent SIRT6 Degradation

  2025cites this paper
• Sirtuins and tumor immunity: mechanistic insights, immunotherapy prospects, and therapeutic horizons

  2025cites this paper
• Forkhead box O proteins: steering the course of stem cell fate

  2024cites this paper
• The Promise of Combination Therapies with FOXM1 Inhibitors for Cancer Treatment

  2024cites this paper
• Effects of Empagliflozin and Dapagliflozin in alleviating cardiac fibrosis through SIRT6-mediated oxidative stress reduction

  2024cites this paper
• Structure-Guided Discovery of Subtype Selective SIRT6 Inhibitors with a β-Carboline Skeleton for the Treatment of Breast Cancer.

  2024cites this paper
• A Novel Prognostic Model of Hepatocellular Carcinoma per Two NAD+ Metabolic Synthesis-Associated Genes

  2024cites this paper
• Activation and inhibition of sirtuins: From bench to bedside

  2024cites this paper
• Implications of Nanotherapeutic advancements to leverage Multi-Drug Resistant Breast Cancer: The State-of-the-Art Review

  2024cites this paper
• ADP-ribosylation, a multifaceted modification: functions and mechanisms in aging and aging-related diseases.

  2024cites this paper
• FOXO3a-interacting proteins’ involvement in cancer: a review

  2024cites this paper
• The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis

  2023cites this paper
• Binding to nucleosome poises human SIRT6 for histone H3 deacetylation

  2023cites this paper
• Discovery of a potent and highly selective inhibitor of SIRT6 against pancreatic cancer metastasis in vivo

  2023cites this paper
• The prognostic and clinicopathological roles of sirtuin-6 in various cancers: A meta-analysis

  2023cites this paper
• SIRT6 promotes metastasis and relapse in HER2-positive breast cancer

  2023cites this paper
• The Role of Sirtuin 6 in the Deacetylation of Histone Proteins as a Factor in the Progression of Neoplastic Disease

  2023cites this paper
• Sirtuin 6—A Key Regulator of Hepatic Lipid Metabolism and Liver Health

  2023cites this paper
• FOXO3a in cancer drug resistance.

  2022cites this paper
• Research progress on the antitumor effects of astragaloside IV.

  2022cites this paper
• Availability of aldo-keto reductase 1C3 and ATP-binding cassette B1 as therapeutic targets for alleviating paclitaxel resistance in breast cancer MCF7 cells.

  2022cites this paper
• miR-338-3p Inhibits Apoptosis Evasion in Huh7 Liver Cancer Cells by Targeting Sirtuin 6

  2022cites this paper
• Sirtuin 6 Is a Critical Epigenetic Regulator of Cancer.

  2022cites this paper
• Quantitative Acetylomics Reveals Dynamics of Protein Lysine Acetylation in Mouse Livers During Aging and Upon the Treatment of Nicotinamide Mononucleotide

  2022cites this paper
• The prognostic implications of SIRTs expression in breast cancer: a systematic review and meta-analysis

  2022influential citation
• The interaction between ETS transcription factor family members and microRNAs: A novel approach to cancer therapy.

  2022cites this paper
• SIRT6 Widely Regulates Aging, Immunity, and Cancer

  2022cites this paper
• Clinicopathological and prognostic value of SIRT6 in patients with solid tumors: a meta-analysis and TCGA data review

  2022cites this paper
• Kaempferol and Apigenin suppresses the stemness properties of TNBC cells by modulating Sirtuins

  2022cites this paper
• Vorinostat Reverses Paclitaxel Resistance Induced by SIRT6 Upregulation Through Enhancing Autophagy in Lung Cancer

  2022cites this paper
• Profiling the regulatory interplay of BET bromodomains and Sirtuins in cancer cell lines.

  2022cites this paper
• MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1

  2022cites this paper
• Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer

  2021cites this paper
• The Two-Faced Role of SIRT6 in Cancer

  2021cites this paper
• Sirtuin 6 regulates the proliferation and survival of clear cell renal cell carcinoma cells via B-cell lymphoma 2

  2021cites this paper
• SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice

  2021influential citation
• Sirtuins as Important Factors in Pathological States and the Role of Their Molecular Activity Modulators

  2021cites this paper
• Sirtuins, healthspan, and longevity in mammals

  2021cites this paper
• Harnessing Reversed Allosteric Communication: A Novel Strategy for Allosteric Drug Discovery.

  2021cites this paper
• Sirtuins as NAD+-dependent deacetylases and their potential in medical therapy

  2021cites this paper
• Highly sensitive and label-free electrochemical biosensor based on gold nanostructures for studying the interaction of prostate cancer gene sequence with epirubicin anti-cancer drug

  2021cites this paper
• Sirtuin signaling in hematologic malignancies

  2021cites this paper
• FOXO transcription factor family in cancer and metastasis

  2020influential citation
• A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2

  2020influential citation
• Sirtuins’ Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion

  2020cites this paper
• Integrative Analysis of Sirtuins and Their Prognostic Significance in Clear Cell Renal Cell Carcinoma

  2020cites this paper
• Sirtuins and their Biological Relevance in Aging and Age-Related Diseases

  2020cites this paper
• How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer.

  2020cites this paper
• Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer

  2020cites this paper
• Structural Insight into the Interactions between Structurally Similar Inhibitors and SIRT6

  2020cites this paper
• Role of Endoplasmic Reticulum ER Stress-Induced Cell Death Mechanisms

  2020cites this paper
• ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer

  2020cites this paper
• Emerging Role of Sirtuins in Breast Cancer Metastasis and Multidrug resistance: Implication for Novel Therapeutic Strategies Targeting Sirtuins.

  2020cites this paper
• Emerging roles of SIRT6 in human diseases and its modulators

  2020cites this paper
• Endoplasmic reticulum stress-induced cell death mechanism

  2020cites this paper
• Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cells.

  2019cites this paper
• Curcumin attenuates migration and invasion of osteosarcoma cells by regulating expression of miR-33b- 5p/SIRT6 axis

  2019cites this paper
• Inhibition of Sirt6 suppresses tumor growth by inducing G1/S phase arrest in renal cancer cells.

  2019cites this paper
• NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma

  2019cites this paper
• Current role of mammalian sirtuins in DNA repair.

  2019cites this paper
• Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation

  2019cites this paper
• Structure-based identification of novel sirtuin inhibitors against triple negative breast cancer: An in silico and in vitro study.

  2019cites this paper
• Sirtuins and SIRT6 in Carcinogenesis and in Diet

  2019cites this paper
• SIRT6, a Mammalian deacylase with multitasking abilities.

  2019cites this paper
• Emerging roles of telomeric chromatin alterations in cancer

  2019cites this paper
• SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy

  2019cites this paper
• Ampelopsin-sodium induces apoptosis in human lung adenocarcinoma cell lines by promoting tubulin polymerization in vitro

  2019cites this paper
• Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells

  2019cites this paper
• Low Rap1-interacting factor 1 and sirtuin 6 expression predict poor outcome in radiotherapy-treated Hodgkin lymphoma patients

  2018cites this paper
• SIRT6 Depletion Sensitizes Human Hepatoma Cells to Chemotherapeutics by Downregulating MDR1 Expression

  2018cites this paper
• Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review.

  2018cites this paper
• Coordination of FOXA2 and SIRT6 suppresses the hepatocellular carcinoma progression through ZEB2 inhibition

  2018cites this paper
• Cell communication via microRNA exchange between endothelial and tumour cells during anti-cancer neoadjuvant chemotherapy

  2018cites this paper
• SIRT6 inhibits colorectal cancer stem cell proliferation by targeting CDC25A.

  2018cites this paper
• Coordination of FOXA 2 and SIRT 6 suppresses the hepatocellular carcinoma progression through ZEB 2 inhibition

  2018cites this paper
• The clinical significance of PINX1 expression in papillary thyroid carcinoma.

  2018cites this paper
• Critical role of FOXO3a in carcinogenesis

  2018cites this paper
• Epigenetics in ovarian cancer: premise, properties, and perspectives

  2018cites this paper
• Pharmacological activation of SIRT6 triggers lethal autophagy in human cancer cells

  2018cites this paper
• Transcriptional upregulation of c‐MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma

  2018cites this paper
• Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity

  2018influential citation
• SIRT6 Is Involved in the Progression of Ovarian Carcinomas via β-Catenin-Mediated Epithelial to Mesenchymal Transition

  2018cites this paper
• Overexpression of Sirt6 is a novel biomarker of malignant human colon carcinoma

  2018cites this paper
• Histone deacetylase SIRT6 inhibits glioma cell growth through down-regulating NOTCH3 expression

  2018cites this paper
• miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6.

  2018cites this paper
• miR-34 a inhibits tumorigenesis of NSCLC via targeting SIRT 6

  2018cites this paper
• ER stress and cancer: The FOXO forkhead transcription factor link.

  2017cites this paper
• SIRT6 is upregulated and associated with cancer aggressiveness in papillary thyroid cancer via BRAF/ERK/Mcl‑1 pathway.

  2017cites this paper
• SIRT6: Novel Mechanisms and Links to Aging and Disease.

  2017cites this paper
• Strong Correlation between the Expression Levels of HDAC4 and SIRT6 in Hematological Malignancies of the Adults

  2017cites this paper
• SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects.

  2017cites this paper
• The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance

  2017cites this paper
• The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3

  2017cites this paper